- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
1-Amino-3-benzyloxy-4-oxo-1,4-dihydropyridine-2-acidi carboxylici ethyl niensis
Product Name:1-Amino-3-benzyloxy-4-oxo-1,4-dihydropyridine-2-acidi carboxylici ethyl niensis
Formulae hypotheticae: C15H16N2O4
Molecular pondus:288.3
CAS Subcriptio Number: 1985607-66-6
3-((2S,5S)-5-((3R,5R)-5-Methyl-3-((methylsulfonyl)oxy)-6-((((trifluoromethyl)sulfonyl)oxy)hept-6-en-1- yl) -4-methylenetetrahydrofuran-2-yl) propyl pivalate
Product Name:3-((2S,5S)-5-((3R,5R)-5-Methyl-3-((methylsulfonyl)oxy)-6-(((trifluoromethyl)sulfonyl)oxy)hept-6-en -1-yl) -4-methylenetetrahydrofuran-2-yl) propyl pivalate
Formulae hypotheticae: C23H37F3O9S2
Molecular pondus:578.66
CAS Registry Number: 871357-66-3
2-((2S,3S,4R,5R)-5-((S)-2,3-bis(tert-butyldimethylsilyloxy) propyl) -4-methoxy-3-(tosylmethyl)tetrahydrofuran-2-yl) acetaldehyde
Product Name:2-((2S,3S,4R,5R)-5-((S)-2,3-bis(tert-butyldimethylsilyloxy)propyl)-4-methoxy-3-(tosylmethyl) tetrahydrofuran-2-yl ) acetaldehyde
Formulae hypotheticae: C30H54O7SSi2
Molecular pondus:614,98
CAS Registry Number: 1808153-90-3
![Methyl 2-((2R,4aS,6S,7R,8S,8aS)-7,8-bis((tert-butyldimethylsilyl)oxy)-6-((S,E)-1-((tert-butyldimethylsilyl) oxy; ) -3-iodoallyl)octahydropyrano[3,2-b]pyran-2-yl)acetate](/upload/6698/methyl-2-2r-4as-6s-7r-8s-8as-7-8-bis-tert-butyldimethylsilyl-oxy-6-s-e-1-tert-butyldimethylsilyl-oxy-3-iodoallyl-octahydropyrano-3-2-b-pyran-2-yl-acetate_787468.gif "Methyl 2-((2R,4aS,6S,7R,8S,8aS)-7,8-bis((tert-butyldimethylsilyl)oxy)-6-((S,E)-1-((tert-butyldimethylsilyl) oxy; ) -3-iodoallyl)octahydropyrano[3,2-b]pyran-2-yl)acetate")
Methyl 2-((2R,4aS,6S,7R,8S,8aS)-7,8-bis((tert-butyldimethylsilyl)oxy)-6-((S,E)-1-((tert-butyldimethylsilyl) oxy; ) -3-iodoallyl)octahydropyrano[3,2-b]pyran-2-yl)acetate
Product Name:Methyl 2-((2R,4aS,6S,7R,8S,8aS)-7,8-bis((tert-butyldimethylsilyl)oxy)-6-((S,E)-1-((tert- butyldimethylsilyl) oxy) -3-iodoallyl)octahydropyrano[3,2-b]pyran-2-yl)acetate
Formulae hypotheticae: C32H63IO7Si3
Molecular Weight:771.01
CAS Subcriptio Number:157322-83-3
Eribulin medium (S)
Product Name: Eribulin medium (S)
Formulae hypotheticae: C70H132O13Si5
Molecular pondus:1322.24
CAS Registry Number: 871360-43-9
Eribulin medium (R)
Product Name: Eribulin medium (R)
Formulae hypotheticae: C70H132O13Si5
Molecular pondus:1322.24
CAS Registry Number: 871360-42-8
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
